Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438514 · ClinicalTrials.gov registry record
Biological Biomarkers in MOMS Partnership
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 20
- Enrollment target
NCT02438514 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 20 participants.
The verdict
NCT02438514 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The investigators propose to evaluate the potential utility of stress-related biomarkers obtained via dried blood spots (DBS) and retinal scans by collecting new data from mothers and children within the New Haven MOMS Partnership, a well-established community-partnered research setting. The proposed research could greatly advance the application of stress-related biomarkers within community-based research by increasing our understanding of how stress, trauma, and depression influence biology in childhood and adulthood, as measured using minimally-invasive approaches.
Interventions
- OTHER Biological Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438514
The ClinicalTrials.gov registry entry for NCT02438514 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biological Sample Collection is the first listed.
NCT02438514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438514 about?
NCT02438514 is a clinical study titled "Biological Biomarkers in MOMS Partnership". The investigators propose to evaluate the potential utility of stress-related biomarkers obtained via dried blood spots (DBS) and retinal scans by collecting new data from mothers and children within the New Haven MOMS Partnership, a well-established community-partnered research setting. The propose...
What is the current status of trial NCT02438514?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2014-11. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02438514?
The interventions under investigation include: Biological Sample Collection (OTHER).
Who is sponsoring clinical trial NCT02438514?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.